A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors
NCT01733004
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
MM-141
Sponsor
Merrimack Pharmaceuticals